[10] Borujerdi R, Adeli SH, Mohammadbeigi A, Aliasl F, Asghari A, Hormati A, et al
"Taking a GLP-1
its a metabolic turning point
Why GLP-1 pills could be a game-changer Several oral GLP-1 pills are in late-stage development and theyre getting closer to hitting the market
Albert Goday has received fees for investigation projects, consulting, and postgraduate training, and has participated in clinical trials sponsored by Almirall, Ascensia, Colegio de Farmacuticos de Barcelona, Esteve, Federacin Farmacutica, Fundacin Catalana Sndrome de Down, Fundaci Gol i Gorina, Instituto de Salud Carlos III, Jansen, Lilly, Menarini, MSD, Mutuam, Novo Nordisk, Pronokal, RedGDPS, Rovi, Sanofi Aventis